Bringing Possibilities to LIFE
End-to-end generic drug services — from API & dossier sourcing to market access across Asia.
The end-to-end partner for generic drug manufacturers in Asia.
Chemill is an end-to-end generic drug services group, headquartered in Hong Kong. We source APIs and dossiers, develop finished dosage forms, and open market access across Asia, so manufacturers can enter new markets faster, cut costs, and reach more patients.
Empowering clients. Driving market success. Fostering sustainable growth.
Making medicines accessible, safe, effective and affordable for everyone.
One partner, the whole journey — from molecule to market.
We cover the entire supply chain so manufacturers can commercialize with confidence across Asia.
API Sourcing
Global network of pre-qualified, high-quality API manufacturers for reliable, cost-effective supply.
- Commercial & precision sourcing
- New-product APIs
- Alternate vendor development
Dossier & FDF Development
Ready-made, validated dossiers and finished dosage forms for seamless market entry.
- FDF dossiers, licensing & supply
- Technology transfer
- CDMO / CMO manufacturing
Market Access
Registration, enlistment and tendering that open public and private channels across the region.
- Drug registration & enlistment
- National / local tendering
- Hospital supply
Distribution & Fulfilment
Last-mile distribution, inventory planning and SCM across traditional and digital channels.
- Inventory planning & SCM
- Multi-channel distribution
- E-commerce reach
Five capabilities. One integrated group.
Engage one unit or the whole chain — every Chemill capability is built to be done-for-you.
API sourcing solutions
Immediate cost savings and enhanced competitive capabilities through comprehensive done-for-you sourcing.
- Commercial API Sourcing
- APIs for New Product Development
- API Manufacturing (CMO / CDMO)
- Precision API Sourcing
- Alternate Vendor Development
Value-added generics
Curated, ready-made, validated project dossiers for seamless market entry and immediate impact.
- Commercial FDF Sourcing
- FDF Dossiers Licensing & Supply
- Technology Transfer
- Project Management
- FDF Manufacturing (CDMO / CMO)
Market access solutions
Immediate access to new markets, leveraging our industry experience and expansive Asian network.
- Market Research
- Drug Registration & Enlistment
- National / Local Tendering
- Hospital Supply & Distribution
- Ethical Sales & Marketing
- Inventory Planning, SCM & Fulfilment
Consumer healthcare
Innovative consumer health and OTC products brought to retail and e-commerce across the region.
- Innovative OTC & devices
- Branding & Localisation
- Key-chain & pharmacy enlistment
- Sales, Marketing & E-commerce
- Cross-border distribution
Innovative arm — biosimilars
Biosimilars, 505(b)(2) and innovative biotech drugs, accelerated into Hong Kong and across Asia.
- Biosimilar registration
- 505(b)(2) products
- NCE / innovative biotech drugs
- Pre-NDA & dossier strategy
- Medical affairs & KOL liaison
- Hospital Authority tendering
Built on people, proven by commitments.
Improving Efficiency & Cost Reduction
Optimizing supply sources and operations to lift partner productivity and competitiveness.
Consistently Generate Value
Creating value for every stakeholder — clients, partners, employees and shareholders.
Highest Quality & Safety
Strict adherence to the highest quality and safety requirements at every step.
Make Choices Available
Giving manufacturers a wide range of suitable choices to excel in their markets.
Actively Create Opportunities
A dynamic environment where principals and partners thrive together.
Timely & Equitable Access
Ensuring safe, effective, affordable medicines reach the patients who need them.
A network built across Asia, trusted around the world.
Greater China
North Asia
South & Southeast Asia
Serviced end-to-end from our Hong Kong hub — public and private hospitals, ethical and retail channels, and cross-border e-commerce across the region.
Channels we cover
Generic Drugs
- Public Sector Hospitals
- Private Sector Hospitals
- Ethical Channels
Offline Coverage
- Key Chain Stores
- Speciality Retail
- Local Pharmacies
- Elderly Homes
Consumer Health
- Online Platforms
- Cross-Border E-commerce
- Hong Kong E-commerce
Trusted by top generic drug companies.
Partner names and marks shown for identification only — subject to partner display permissions.
A quarter-century of building access.
Chemillennium International incorporated — pioneering API trade between India & China.
Chemill Inc. USA — distributing nutraceuticals across North America.
Acquired a GSP-licensed drug distribution company in China.
First generic FDF product approval in Hong Kong.
Chemill Pharma launched — first-to-market generics in Hong Kong.
Chemillennium evolves into a dedicated API sourcing company.
Chemill Pharma Ltd. established as an independent entity.
Chemill ValueLIFE — consumer healthcare division — launched.
Group rebrands to CHEMILL: full-spectrum generic drug services.
A quarter-century in Asia — 200+ clients across 38+ countries, 120+ API clients.
Chemill BIOpharma launched — biosimilars, 505(b)(2) and innovative biotech drugs, accelerated into Hong Kong and across Asia.
“At Chemill, we stand committed to transforming possibilities into realities. Our unwavering dedication to excellence, precision, and accessibility fuels our mission to provide high-quality, affordable healthcare solutions. As we evolve, we promise to continue shaping a healthier, more connected world for all.”
Unlock Value. Increase Impact. Expand your Reach.
Whether you need pre-developed dossiers, regulatory guidance, or reliable API & FDF supply — our specialists are ready.